Cargando…

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)

SIMPLE SUMMARY: Ketamine has demonstrated rapid antidepressant effects, but has been minimally studied in cancer populations. We conducted an open-label trial evaluating ketamine for depression in patients with advanced cancer. Participants received three flexible doses of intranasal (IN) ketamine (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenblat, Joshua D., deVries, Froukje E., Doyle, Zoe, McIntyre, Roger S., Rodin, Gary, Zimmermann, Camilla, Mak, Ernie, Hannon, Breffni, Schulz-Quach, Christian, Kindy, Aida Al, Patel, Zeal, Li, Madeline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857323/ https://www.ncbi.nlm.nih.gov/pubmed/36672348 http://dx.doi.org/10.3390/cancers15020400

Ejemplares similares

A comparison of intranasal ketamine and intranasal midazolam for pediatric premedication
por: Narendra, P. L., et al.
Publicado: (2015)

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
por: Chisamore, Noah, et al.
Publicado: (2023)

Comparative Study of Intranasal Dexmedetomidine Versus Intranasal Ketamine as Premedicant in Children
por: Arun, Nidhi, et al.
Publicado: (2022)

Intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients
por: Nasr Isfahani, Mehdi, et al.
Publicado: (2022)

Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study
por: Gutierrez, Gilmar, et al.
Publicado: (2022)

Family physicians' involvement in palliative cancer care
por: Moon, Christine C., et al.
Publicado: (2022)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
por: Rosenblat, Joshua D., et al.
Publicado: (2017)

Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
por: Cossovel, Francesca, et al.
Publicado: (2022)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Palliative care provision at a tertiary cancer center during a global pandemic
por: Hannon, Breffni, et al.
Publicado: (2020)

Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster‐randomized controlled trial in patients with advanced cancer
por: Rodin, Rebecca, et al.
Publicado: (2022)

3447 Effects of intranasal ketamine on uncontrolled cancer related pain
por: Singh, Vinita, et al.
Publicado: (2019)

S-ketamine and intranasal application: alternatives for the castration of male suckling piglets?
por: Becker, Sabrina, et al.
Publicado: (2021)

Comparison of Intranasal Dexmedetomidine and Oral Ketamine Versus Intranasal Midazolam Premedication for Children Undergoing Dental Rehabilitation
por: Oriby, Mohamed E
Publicado: (2019)

Intranasal ketamine for procedural sedation and analgesia in children: A systematic review
por: Poonai, Naveen, et al.
Publicado: (2017)

Intranasal Ketamine for Acute Pain: Behavioral and Neurophysiological Safety Analysis in Mice
por: Goswami, Nidhi, et al.
Publicado: (2021)

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Rosenblat, Joshua D, et al.
Publicado: (2015)

Suicide prevention and ketamine: insights from computational modeling
por: Charlton, Colleen E., et al.
Publicado: (2023)

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
por: Keeler, Johanna Louise, et al.
Publicado: (2023)

Models of Integration of Specialized Palliative Care with Oncology
por: Mathews, Jean, et al.
Publicado: (2021)

Palliative Care Development in Africa: Lessons From Uganda and Kenya
por: Fraser, Brooke A., et al.
Publicado: (2017)

Different agglomeration properties of PC(61)BM and PC(71)BM in photovoltaic inks – a spin-echo SANS study
por: Bernardo, Gabriel, et al.
Publicado: (2020)

Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
por: Rosenblat, Joshua D., et al.
Publicado: (2021)

Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial
por: Vaishnavi, BD, et al.
Publicado: (2023)

Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time
por: Castro, Jacqueline Alcalde, et al.
Publicado: (2023)

Intranasal Dexmedetomidine Compared to a Combination of Intranasal Dexmedetomidine with Ketamine for Sedation of Children Requiring Dental Treatment: A Randomized Clinical Trial
por: Sado-Filho, Joji, et al.
Publicado: (2021)

Efficacy and safety of intranasal midazolam versus intranasal ketamine as sedative premedication in pediatric patients: a meta-analysis of randomized controlled trials
por: Lang, Bingchen, et al.
Publicado: (2022)

Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs
por: Vlerick, Lise, et al.
Publicado: (2020)

Oral and Intranasal Ketamine Use in Treatment-Resistant Catatonia: A Clinical Case Report
por: Gregor, Elizabeth, et al.
Publicado: (2023)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Ketamine for bipolar depression: an updated systematic review
por: Fancy, Farhan, et al.
Publicado: (2023)

Ketamine Enhances Intranasal Dexmedetomidine-Induced Sedation in Children: A Randomized, Double-Blind Trial
por: Qian, Bin, et al.
Publicado: (2020)

Efficacy of intranasal ketamine and midazolam for pediatric sedation: A double-blind, randomized clinical trial
por: Khoshrang, Hossein, et al.
Publicado: (2021)

Procedural sedation in children for fractionated radiation treatment: Intranasal dexmedetomidine versus oral midazolam and ketamine
por: Das, Rekha, et al.
Publicado: (2022)

Intranasal Atomization of Ketamine, Medetomidine and Butorphanol in Pet Rabbits Using a Mucosal Atomization Device
por: Mauthe von Degerfeld, Mitzy, et al.
Publicado: (2023)

Caregiver bereavement outcomes in advanced cancer: associations with quality of death and patient age
por: Mah, Kenneth, et al.
Publicado: (2021)

Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells
por: Singh, Nagendra S., et al.
Publicado: (2016)

Administration of Ketamine Causes Autophagy and Apoptosis in the Rat Fetal Hippocampus and in PC12 Cells
por: Li, Xinran, et al.
Publicado: (2018)

The analgesic effect of combined treatment with intranasal S-ketamine and intranasal midazolam compared with morphine patient-controlled analgesia in spinal surgery patients: a pilot study
por: Riediger, Christine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_51e51qelr171uqml9f6n1h44e7